The company also said it has been awarded a research sequencing grant from Illumina Accelerator.
The former cofounder of Knome believes that the future of precision medicine lies in our ability to program living things to act as medicines.
The companies will integrate PierianDx's informatics solution with two of Illumina's NGS cancer research panels and as well as future IVD products.
Allscripts subsidiary 2bPrecise will work with startup PierianDx to combine NGS and clinical data as they seek to advance precision care for cancer patients.
Malaysia-based ScienceVision has agreed to commercialize and distribute the PierianDx Clinical Genomics Workspace platform in Southeast Asian countries.
The firms will work to accelerate the adoption of PierianDx's genomics platform for translating data into patient-specific diagnoses and treatments.
The companies will join their respective technologies into a precision oncology testing and analysis offering.
WUSTL bioinformatics spinout PierianDx disclosed in an SEC filing that it has raised slightly more than $3 million of a $5 million offering.
As PierianDx grows, two customers weighed in on their experiences with the core product, the Clinical Genomicist Workspace, and its NGS-related services.
Tute will offer interpretation and annotation software from Knome's KnoSys appliance as part of its existing cloud offering but is open to providing a local option for interested clients.
Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.
Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.
Slate's Jane Hu compares some at-home genetic tests to astrology.
In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.